Abstract: The present invention describes material and methods related to synthetic peptides which block the secretion of neurotransmitters and induce muscle relaxation, and use of said peptides as inhibitors of neurotransmitter secretion and muscle contraction, and as inducers of muscle relaxation.

Abstract: A method of extracting oil from algae by drying algae paste to a predetermined moisture content, contacting the algae paste with a polar solvent to make an algae-solvent solution and extracting oils from the algae paste into a solvent-oil solution, and separating extracted algae from the solvent-oil solution. An oil of whole and unhydrolyzed phospholipids, whole and unhydrolyzed glycolipids, lysolipids, and carotenoids extracted by the above method. An omega-3 fatty acid of docosahexanoic acids (DHAs) and eicosapentaenoic acids (EPAs) extracted from the above method. Isolated nutraceutical grade and pharmaceutical grade oil derived from algae and being free of toxins extracted by the above method. Isolated oil derived from algae including at least one omega-3 fatty acid of DHA and EPA at least partially in the form of whole and unhydrolyzed phospholipids and whole and unhydrolyzed glycolipids extracted by the above method.

Abstract: A composition of matter comprises a shelf stable, super critical, CO2 fluid extracted seed oil derived from a cracked biomass of perilla frutescens, the seed oil comprising from about 60 to about 95 percent w/w of PUFAs in a ratio of from about 4:1 to about 6:1 alpha-linolenic acid (ALA) to linoleic acid (LA) and a mixture of selected antioxidants.

Abstract: This invention relates generally to a method of preparation of a phyto-percolate that is derived from fresh water mixture including algae. The invention further relates to the use of the phyto-percolate in a variety of disease states. The phyto-percolate is believed to contain an activity that induces the reduction of soluble and insoluble fibrin. Further, the phyto-percolate is believed to reduce oxidative stress in the body.

Abstract: A microalgae extract is disclosed consisting of: (A) 40-95 wt. % of a polar phase comprising: (i) 15-75 wt. % water; (ii) 20-80 wt. % of alcohols, acetone and/or combinations thereof; (iii) 0-10 wt. % of sodium chloride; (iv) up to 40 wt. % of other water soluble components; (B) 5-60 wt. % of an apolar phase comprising: (i) 70-99.5 wt. % of triglycerides, diglycerides, monoglycerides, phosphatides, free fatty acids and/or combinations thereof; (ii) 0.05-25 wt. % of oil-soluble pigment; (iii) up to 30 wt. % of other oil soluble components; and (iv) optionally other components in a concentration that does not exceed 9% by weight of the water contained in the extract, wherein the extract contains less than 0.5% by weight of the apolar phase of apolar organic solvent selected from C5-C10 alkanes. Processes for extracting an oil-soluble pigment from wet biomass of micro-organisms are also disclosed.

Abstract: It is an object of the present invention to provide a composition containing lactoferrin and another component and having a prominent effect of promoting visceral lipolysis. That is, the present invention is a composition for promoting the lipolysis; a food product, a feedstuff or a pharmaceutical product including (A) lactoferrin and (B) one or more ingredients selected from the group consisting of a Durvillaea extract, raspberry ketone, an artichoke leaf extract, a rosemary extract, isoflavone, a grape seed extract, a pine bark extract, a Coleus forskohlii extract, and a cacao extract. Also provided is a method of giving the effect of promoting the lipolysis to the food product or the feedstuff by adding the component (A) and the component (B) for promoting the lipolysis to the food product or the feedstuff.

Abstract: Methods for selective extraction and fractionation of algal proteins from an algal biomass or algal culture are disclosed. A method of selective removal of products from an algal biomass provides for single and multistep extraction processes which allow for efficient separation of algal proteins. These proteins can be used as renewable sources of proteins for animal feedstocks and human food. Further, lipids remaining in the algal biomass after extraction of proteins can be used to generate renewable fuels.

Abstract: The present invention describes cosmetic or dermatological preparations which contain snow algae extracts and one or several substances which are suitable for skin protection.

Abstract: Disclosed are methods and compositions for the treatment of a variety of disorders in subjects by affecting the glycocalyx of a subject in need of such treatment. The methods comprise administering to a subject an effective amount of a sulfated polysaccharide (SP) or analogue thereof, the SP being a non-animal based (e.g., plant, or bacteria derived) sulfated polysaccharide. The SPs can be administered as single agents, or in combination with one another, or with other medications to promote efficacy. Pharmaceutical compositions and comestibles including such SPs are also described.

Abstract: The invention provides cosmetic compositions comprising microalgal biomass, whole microalgal cells, and/or microalgal oil in combination with one or more other cosmetic ingredients, and methods of making such compositions. In preferred embodiments, the microalgal components of the cosmetic compositions are derived from microalgal cultures grown heterotrophically and which comprise at least 10% oil by dry weight.

Abstract: Various embodiments of the present invention refer to a new process for transforming Lithothamnium seaweeds and obtaining a marine mineral concentrate made from Lithothamnium seaweed having superior and differentiated properties and activities.

Abstract: A process for manufacturing fire resistant materials comprising the steps of recovering an alga having a mineral component wherein said alga is selected form the group consisting of Chara algae and Cladophora algae; mixing said algae with water to form an aqueous mixture; mixing a chlorine based solution to the mixture to kill the algae and any bacteria and to form an algae-based product; separating the algae-based product from the aqueous mixture; and recovering the algae-based product from the surface of the mixture.

Abstract: An NF-?B inhibitor which can be easily obtained and consumed in daily dietary life and can inhibit transcription activation by NF-?B is provided. When osteoblasts in which NF-?B is activated by TNF-? is cultured in a medium containing Sargassum horneri or a processed product thereof, for example, a Sargassum horneri water extract of molecular weight up to 3,000, transcription activation by NF-?B can be inhibited. In addition, when osteoclast precursor cells in which NF-?B is activated by RANKL is cultured in a medium containing Sargassum horneri or a processed product, for example, a Sargassum horneri water extract thereof of molecular weight up to 3,000, transcription activation by NF-?B can be inhibited.

Abstract: Provided is a method for improving day photopic vision and/or cone-derived visual field and visual function in a subject suffering from a retinal disease or trauma including administering to the subject a pharmaceutically effective amount of crude Dunaliella powder. Also provided is a method for improving night vision and/or rod derived visual field in a subject suffering from a retinal disease including administering to the subject a pharmaceutically effective amount of crude Dunaliella powder. A pharmaceutical composition for improving day vision and/or visual field in a subject suffering from a retinal disease including crude Dunaliella powder is also provided.

Abstract: A method of reducing a weight of a subject includes administering to the subject in need thereof a composition comprised of fucoxanthin extract and at least one selected from the group consisting of tocotrienol, fucoidan and a combination thereof, wherein the subject is a mammal.

Abstract: The object of the invention is the use in a cosmetic composition of an effective amount of at least one cutaneous cell autophagy activator as a cosmetic active ingredient. The invention also relates to cosmetic compositions that include at least one cutaneous cell autophagy activator as a cosmetic active ingredient 5 and a cosmetic process for detoxifying skin and/or for preventing or combating cutaneous aging.

Abstract: Disclosed is a topical skin cleanser comprising Silybum marianum fruit extract, Momordica grosvenorii fruit extract, and a cosmetic vehicle comprising at least 50% by weight of the composition of water and disodium EDTA, glycerin, phenoxyethanol, triethanolamine, 3-Iodo-2-propynyl butyl carbamate, and benzyl alcohol.

Abstract: A treatment protocol for use in the treatment of neurocutaneous syndrome is described and comprises at least one xanthone component, which may comprise at least one mangosteen component, and at least one detoxification component. Additional embodiments comprise at least one herbal component, at least one vitamin component, or a combination thereof. A method of treating a patient having neurocutaneous syndrome is described herein and comprises: providing at least one xanthone component, which may comprise at least one mangosteen component, providing at least one xanthone component, which may comprise at least one mangosteen component, to the patient, and administering the at least one detoxification component to the patient. Additional methods steps may include providing and administering at least one herbal component, providing and administering at least one vitamin component or a combination thereof.

Abstract: A dietary supplement containing a source of ellagic acid, such as black raspberry seed powder, is combined with one or more of blue green algae, brown seaweed, phycocyanin and phenylathylemine. Additions of one or more vitamins and/or one or more minerals further improves the health enhancing benefits of the dietary supplement.

Abstract: The present invention relates to a method of preventing or treating allergic diseases such as allergic rhinitis, atopic dermatitis, anaphylaxis, and asthma, which comprises administering an extract of Laurencie undulata in a therapeutically effective amount to a patient in need thereof.

Abstract: Disclosed are compositions of matter, uses, and therapeutic interventions directed towards modulation of stem cell activity in a mammal. In particular the invention provides compositions whose end result modulates health, wellbeing, longevity and function of organ systems. Within the scope of the invention are biologically active extracts, components thereof, and compositions (such as cosmetic or pharmaceutical preparations) made comprising such.

Abstract: The present disclosure describes various building materials used in the building and construction industry, and to buildings or objects constructed therefrom, and to methods of making these building materials. The building materials comprise a polymeric material, such as sodium alginate and/or calcium alginate which confers significant flame-, fire- and heat-resistance or imperviousness to the materials. Other substances can be added to the materials to improve cross-linking and/or to produce resistance to fungal degradation. The building materials which can be produced, processed, or treated using the alginate polymers of the invention include, but are not limited to, wood products; masonry products; wall, roofing, flooring and siding products; and paint products. Further, sodium alginate in the form of a gel may be used as a firebreak to effectively stop the advance of grass fires, wildfires, and forest fires.

Abstract: The present invention relates to skin care compositions comprising blends of camellia and feverfew serum fractions and/or kelp and parsley serum fractions. The skin care compositions also comprise a dermatologically acceptable carrier. The invention also relates to methods for increasing melanin production in skin by topically applying the skin care composition to areas in order to stimulate one or more steps in melanin synthesis and/or interrupt an inflammatory cycle.

Abstract: Disclosed is a topical skin composition comprising water, a first algae extract comprising Crithmum maritimum, a second algae extract comprising Ulva lactuca, and a third algae extract.

Abstract: Provided herein is an extremophile green alga designated as Scenedesmus species Novo, from Jemez warm water springs, New Mexico. Sequencing 18S rDNA confirmed the alga as a new species. It is capable of producing high levels of microalgal biomass in wastewater under harsh ambient climatic conditions, and of yielding high levels of lipids and carotenes. Cultures in TAP medium at 24±1° C. at continuous light (132-148 ?mol photons m?2s?1) attained peak biomass levels 27.4×106 cells ml?1, 49.11 ?g ml?1 chlorophyll ?, 24.93 ?g ml?1 carotene on the seventh day and a division rate of 0.54 day?1. High levels of biomass were sustained in sterilized and unsterilized municipal wastewater, enriched with 1% TAP nutrients or unenriched. The microalga is useful in the production of biofuels, fertilizers, dietary nutrients, pharmaceuticals, polymers, biofilters to remove nutrients and other pollutants from wastewaters, in space technology, and laboratory research systems.

Abstract: In an embodiment of the invention, aqueous growth medium in a pond can be used to grow algae which can be pumped to a primary dewatering device where the algae can be separated from the harvested growth media based on the flow of the harvested growth media and gravity. The flow through the primary de-watering device can be optimized to maintain log phase growth in the pond, while minimizing the pumping cost and maximizing the concentration of total solids in the primary de-watered algae.

Abstract: A composition comprises extract of fucoxanthin, wherein said composition further comprises tocotrienols and/or fucoidan. Said composition can be used to treat obesity. Said composition shows outstanding effect of weight loss. There is outstanding synergy effect among those constituents of the composition.

Abstract: Methods for modifying a microalgal lipid by subjecting the lipid to a chemical reaction are provided, the lipid containing no more than 500 ppm color-generating impurities and obtained from Parachlorella, Prototheca, or Chlorella microalgal strains, or strains having at least 85% nucleotide sequence identity in 23S rRNA sequences to such strains grown under heterotrophic conditions.

Abstract: Disclosed here are compositions rich in omega-7 fatty acids, including palmitoleic acid, and products rich in omega-7 fatty acids derived from algal biomass. The algae and/or compositions rich in omega-7 fatty acids may be used in products or as ingredients of products. Methods and systems for increasing the production or concentration of omega-7 fatty acids, and isolating omega-7 fatty acids from algal biomass are also disclosed herein.

Abstract: Compositions comprising a moisturizing agent, a desquamating agent, a mattifying agent and an agent that increases skin luminosity are disclosed herein. The compositions are useful for moisturizing, desquamating, mattifying, and increasing the luminosity in skin of an individual having a Fitzpatrick Skin Type IV, V, or VI. Also disclosed are methods for moisturizing, desquamating, mattifying, and increasing the luminosity in skin, comprising administering to an individual having a Fitzpatrick Skin Type IV, V, or VI, the present compositions.

Abstract: The invention relates to adhesives for medical applications and methods of their preparation and use.

Abstract: A process for manufacturing fire resistant materials comprising the steps of recovering Cladophora algae; mixing said algae with water to form an aqueous mixture; mixing a chlorine based solution to the mixture to kill the algae and any bacteria and to form an algae-based product; allowing the algae-based product to separate and rise to the surface of the aqueous mixture; skimming the algae-based product from the surface of the mixture; drying said recovered algae-based product; and recovering the dried algae-based product.

Abstract: A method of using fucoidan to enhance stem cell mobilization in a subject, including hematopoietic stem cells (HSCs) and bone marrow stem cells (BMSCs) is provided. In the method, a blended composition of fruits, mushrooms, microorganisms, maternal fluids, and extracts thereof are used to promote trafficking of stem cells, resulting in migration of the stem cells to specific sties of maintenance an and repair within tissues and/or organs. The method also involves the use of fucoidan obtained from particular algae species to support release and circulation of HSCs, as demonstrated by significantly increase circulation of HSCs in the peripheral blood. Increased circulation of HSCs and/or BMSCs and migration towards sites of maintenance and the natural regeneration mechanisms in the body. Further provided is a dosing regimen for the administration of fucoidan and a method of enhancing release and circulation of stem cells.

Abstract: The present invention relates to a hair growth stimulator based on an Ecklonia cava extract, a preparation method thereof and a cosmetic composition containing the same. Dioxinodehydroeckol is isolated from the Ecklonia cava extract. The Ecklonia cava extract prepared according to the preparation method and the dioxinodehydroeckol compound have excellent hair growth effects which are significantly higher than the effect of an Ecklonia cava extract prepared according to a conventional method.

Abstract: Consumption of blue-green algae, or extracts thereof, enhances trafficking or homing of stem cells in animals by inducing a transient increase in the population of stem cells present in the animal's circulatory system. The animal may be healthy or suffering some disease or physiological condition.

Abstract: Methods and compositions for increasing intestinal transport of nutrients or growth performance in the offspring of an animal are described. More specifically, a feed composition comprising an omega-3 fatty acid-containing composition for increasing intestinal transport of nutrients or growth performance in the offspring of the animal, and methods therefor, are described.

Abstract: Disclosed herein is a composition for suppressing and preventing obesity and related adult diseases, comprising Herba Ephedrae and Thallus Laminariae seu Eckloniae, or comprising Herba Ephedrae, Thallus Laminariae seu Eckloniae and Radix et Rhizoma Rhei.

Abstract: A nutritional supplement includes the primary ingredients: N-acetyl D-glucosamine, cracked cell wall Green Chlorella, Licorice Root Extract, and Potassium Citrate, as well as secondary ingredients: Zinc L-Carnosine, Gamma-Oryzanol and Capsaicin, that improves the bodies uptake, utilization and over-all bioavailability of exogenous target protein fractions (TPF) including but not limited to: glycoproteins, (such as glucosamine) protein isolates as amino acids, glycosaminoglycans (GAG) (including proteoglycans, and mucopolysaccharides), and polysaccharides such as hyaluronic acid (hyaluronan). The biochemical interactions of the composition improves zeta potential for TPF incorporation in the body through direct and indirect interaction with primary cellular and digestive sites of multiple species.

Abstract: It comprises a combination of glycerin, niacinamide, and an extract of Fucus Serratus, to topical pharmaceutical or cosmetic compositions containing them, processes for their preparations, as well as their pharmaceutical use in the prophylaxis and/or treatment of disease or conditions that transcur through a deficit of maturation of the cornified envelope, and their cosmetical use as a skin care agent, skin barrier recovery agent, and moisturizer.

Abstract: Novel methods and compositions for treating aged and environmentally damaged skin are disclosed which provide improvements in the skin's visual appearance, function and clinical/biophysical properties by activating at least one proteolytic enzyme in the skin's stratum corneum. The disclosed treatment methods involve topical application of a novel cosmetic composition containing a combination of a cationic surfactant such as N,N,-dimethyldodecyl amine oxide (DMDAO), an anionic surfactant such as sodium dodecyl sulfate (SDS), or monoalkyl phosphate (MAP) and a chelating agent such as ethylene diamine tetraacetate (EDTA) to stimulate a chronic increase in the replacement rate of the skin's stratum corneum by means of corneum protease activation. This chronic, low level stimulation is effective to induce repair and replacement of the stratum corneum, epidermis, and dermis of the skin and improvements in the appearance, function, and anti-aging properties of the skin.

Abstract: A topical skin care composition and method for its use comprising water, Chlorella vulgaris extract, an algae extract, a phospholipid or lecithin, glycerin, retinyl palmitate, tocopheryl acetate, and magnesium ascorbyl phosphate.

Abstract: A molded food product is provided that has a high fat and protein content and a low carbohydrate content. The food product is suitable for human or animal consumption. The food product can serve as a snack or as a carrier for active ingredients such as vitamins, minerals, herbs and other food additives.

Abstract: The invention relates to the use in a cosmetic composition of an extract of the alga Phaeodactylum tricornutum, as a depigmenting active agent intended in particular for attenuating or eliminating skin pigmentation marks or for lightening the complexion or bodily hairs or head hair. The extract is preferably a lipid extract. The invention also relates to a cosmetic care method for attenuating or eliminating skin pigmentation marks or for lightening the complexion or bodily hairs or head hair, characterized in that it comprises the application, to at least one concerned area of the skin, of a cosmetic composition containing this extract.

Abstract: A composition for a medicinal or health effect of a treatment of liver fat and body fat, a reduction of blood pressure, an increase of the energy expenditure rate, a reduction of inflammatory C-reactive proteins and a reduction of plasma aminotransferase enzymes, comprising an effective amount of fucoxanthin alone or in combination with pomegranate seed oil, a pharmaceutically acceptable salt, a prodrug thereof, or a salt of the prodrug; and a method of using the same. The fucoxanthin may be used in pure form, or as a component of a brown marine vegetable extract.

Abstract: The present invention relates to a functional beverage composition comprising chlorella and deep sea water. The composition comprises 0.1-5 wt % of chlorella powder, 90-99 wt % of deep sea water, 0.001-0.5 wt % of a grapefruit extract, 0.01-5 wt % of honey, 0.01-5 wt of polydextrose, 0.001-1 wt % of citric acid, and 0.001-0.1 wt % of enzyme-treated stevia. Thus, the functional properties of deep sea water and chlorella, including antioxidant, anticancer, anti-inflammatory, cerebral vascular and cardiovascular disease inhibitory and anti-diabetic functions, can be provided by taking the beverage composition.

Abstract: A method of improving the appearance of a hyperpigmented spot may comprise the step of applying a composition comprising a safe and effective amount of an Laminaria Saccharina extract to a hyperpigmented spot on a skin surface, wherein the composition is applied for a period of time sufficient for the Laminaria Saccharina extract to improve the appearance of the hyperpigmented spot. The method may include the step of identifying a hyperpigmented spot on a facial skin surface. Other methods as disclosed include a method for improving the appearance of post-inflammatory hyperpigmentation.

Abstract: A method of inhibiting tyrosinase activity may involve the step of applying a composition comprising a Laminaria Saccharina extract to a substrate in need of tyrosinase inhibition. The method may further comprise a step of identifying a substrate in need of tyrosinase inhibition. The composition may be left on the substrate and/or repeatedly applied to the substrate to achieve the desired inhibition of tyrosinase activity.

Abstract: The present invention provides a substance which can modulate expression of a Bmal gene effectively and with a wide range of application. Provided is an expression modulator for the Bmal gene comprising, as an active ingredient, one or more selected from the group consisting of hinoki cypress extract, chlorella extract, hop extract, Zanthoxylum extract, juniper oil, lavender oil, eucalyptus oil, olibanum, cypress oil, palmarosa oil, pineneedle oil, rose oil, ylang-ylang oil, elemi oil, petitgrain oil, pepper oil, thyme oil and chamomile oil.

Abstract: The present invention relates to a method for preparing chlorophyll-a and chlorin e6. This invention extracts chlorophyll-a by use of undisrupted chlorella cells themselves, thereby preparing chlorin e6 from the chlorophyll-a extract. The high contents of chlorophyll-a may be obtained by the pretreatment procedure of chlorella cells themselves selected in this invention. The present method is performed according to relatively simple procedures, and is suitable in the mass production of chlorin e6.

Abstract: Provided herein are microalgal skin care compositions and methods of improving the health and appearance of skin. Also provided are methods of using polysaccharides for applications such as topical personal care products, cosmetics, and wrinkle reduction compositions. The invention also provides novel decolorized microalgal compositions useful for improving the health and appearance of skin. The invention also includes insoluble polysaccharide particles for application to human skin.